| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... Nature communications 10 (1), 1-20, 2019 | 291 | 2019 |
| Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice B Lee, KM Robinson, KJ McHugh, EV Scheller, S Mandalapu, C Chen, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 309 (2 …, 2015 | 136 | 2015 |
| Removal of HIV DNA by CRISPR from patient blood engrafts in humanized mice R Bella, R Kaminski, P Mancuso, WB Young, C Chen, R Sariyer, T Fischer, ... Molecular Therapy-Nucleic Acids 12, 275-282, 2018 | 99 | 2018 |
| Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria YP Di, Q Lin, C Chen, RC Montelaro, Y Doi, B Deslouches Science advances 6 (18), eaay6817, 2020 | 88 | 2020 |
| CRISPR based editing of SIV proviral DNA in ART treated non-human primates P Mancuso, C Chen, R Kaminski, J Gordon, S Liao, JA Robinson, ... Nature communications 11 (1), 6065, 2020 | 79 | 2020 |
| Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia C Chen, B Deslouches, RC Montelaro, YP Di Clinical Microbiology and Infection 24 (5), 547. e1-547. e8, 2018 | 45 | 2018 |
| In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection C Chen, ML Mangoni, YP Di Scientific Reports 7 (1), 8548, 2017 | 43 | 2017 |
| Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence D Volonte, AR Vyas, C Chen, S Dacic, LP Stabile, BF Kurland, ... Journal of Biological Chemistry 293 (5), 1794-1809, 2018 | 42 | 2018 |
| Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2 F Liu, Z Cai, J Huang, H Niu, W Yu, Y Zhang, T Yan, C Chen, Y Liu, A Xu Journal of Microbiology, Immunology and Infection 54 (1), 101-104, 2021 | 21 | 2021 |
| Antibacterial properties and efficacy of a novel SPLUNC1-derived antimicrobial peptide, α4-short, in a murine model of respiratory infection S Jiang, B Deslouches, C Chen, ME Di, YP Di MBio 10 (2), 10.1128/mbio. 00226-19, 2019 | 21 | 2019 |
| CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice PK Dash, C Chen, R Kaminski, H Su, P Mancuso, B Sillman, C Zhang, ... Proceedings of the National Academy of Sciences 120 (19), e2217887120, 2023 | 15 | 2023 |
| Latent membrane protein 1 is a novel determinant of Epstein-Barr virus genome persistence and reactivation EA Caves, RM Butch, SA Cook, LR Wasil, C Chen, YP Di, N Lee, ... Msphere 2 (6), 10.1128/mspheredirect. 00453-17, 2017 | 12 | 2017 |
| Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates TH Burdo, C Chen, R Kaminski, IK Sariyer, P Mancuso, M Donadoni, ... Gene Therapy, 1-10, 2023 | 10 | 2023 |
| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun 10: 2753 PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... | 8 | 2019 |
| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun. 2019; 10: 2753 PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi | 6 | |
| Longitudinal progression of estimated GFR in HIV-1-infected patients with normal renal function on tenofovir-based therapy in China F Liu, A Xu, H Zhao, Z Yang, C Chen, B Ranieri, J Bao, G Zheng, M Wang, ... Therapeutics and Clinical Risk Management, 299-310, 2020 | 5 | 2020 |
| Urinary bladder matrix protects host in a murine model of bacterial-induced lung infection C Chen, X Zhang, Q Lin, NT Remlinger, TW Gilbert, YP Di Tissue Engineering Part A 25 (3-4), 257-270, 2019 | 3 | 2019 |
| Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells H Liu, C Chen, S Liao, DK Sohaii, CRY Cruz, TH Burdo, TJ Cradick, ... Molecular Therapy-Nucleic Acids 32, 1010-1025, 2023 | 2 | 2023 |
| iNOS 在 EGCG 促 A549 细胞凋亡中的作用 任姸， 曹留霞， 张静， 刘晓萍， 卞晶晶， 陈琛 齐鲁医学杂志, 286-288, 2014 | 2 | 2014 |
| Correction: Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates TH Burdo, C Chen, R Kaminski, IK Sariyer, P Mancuso, M Donadoni, ... Gene therapy, 2024 | | 2024 |
Peter DiUniversity of PittsburghVerified email at pitt.edu
